Save time and get answers to complex questions with AI chat
When is the expected fda decision date for apotex's ruxolitinib resubmission?Is januvia still on the market?Tenofovir generic patent?Excipients list used in dexamethasone creams?Guselkumab brand name?
See the DrugPatentWatch profile for lurbinectedin
In cancer treatment with lurbinectedin, there isn’t a single exact “onset” time. The usual way to gauge full or best effect is with imaging after a couple of treatment cycles, not after a single dose. - Typical evaluation point: after about 2 cycles of lurbinectedin (roughly 6 weeks). This is when doctors often assess for response (shrinkage of tumors or progression/stability). - What to expect: some patients may show early signs of benefit after the first cycle, but the greatest or “full” effect is usually seen after 2–3 cycles (around 6–9 weeks), and sometimes even a bit later depending on the individual. - If there’s no meaningful response after 2–3 cycles or if toxicity is limiting, the treating clinician may adjust or stop therapy. Keep in mind: - Response time varies between individuals. - Imaging to assess response is typically scheduled by the oncologist (often after every 2 cycles). - The duration of any response, if it occurs, can last for months, but is also variable. If you’re asking about a specific patient, I can help interpret general timelines, but please consult the treating oncologist for guidance tailored to that person’s situation.
Other Questions About Lurbinectedin :